Gene · 6599
Papers1,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FET fusion oncoproteins enrich SWI/SNF complex subtypes and interaction partners. | Cell Mol Biol Lett | 2025 | 40988026 | PubTator, text mining | PubMed |
| Requirements for establishment and epigenetic stability of mammalian heterochromatin. | Mol Cell | 2025 | 40972525 | PubTator, text mining | PubMed |
| SMARCA2 Deficiency While Preserving SMARCA4 in Lung Adenocarcinoma Combined with Abnormal β-Catenin Expression. | Cancer Manag Res | 2025 | 40964496 | PubTator, text mining | PubMed |
| A novel SWI/SNF complex promotes triple-negative breast cancer progression. | Cell Mol Biol Lett | 2025 | 40890601 | PubTator, text mining | PubMed |
| Phosphoproteomic insights into GFPT2-Associated cellular phospho-signaling networks. | Biochem Biophys Rep | 2025 | 40808719 | PubTator, text mining | PubMed |
| The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma. | Blood Cancer J | 2025 | 40739087 | PubTator, text mining | PubMed |
| Gene2role: a role-based gene embedding method for comparative analysis of signed gene regulatory networks. | BMC Bioinformatics | 2025 | 40413377 | PubTator, text mining | PubMed |
| Inflammatory metabolite 7α,25-OHC promotes TIMP1 expression in COVID-19 monocytes through synergy effect of SMARCC1/JUND/H3K27ac. | Cell Mol Life Sci | 2025 | 40399563 | PubTator, text mining | PubMed |
| SMARCA4 deficiency: implications for non-small cell lung cancer and management strategies, with relevance to and distinctions from thoracic undifferentiated tumor. | Transl Lung Cancer Res | 2025 | 40386720 | PubTator, text mining | PubMed |
| Identification and targeting of regulators of SARS-CoV-2-host interactions in the airway epithelium. | Sci Adv | 2025 | 40378209 | PubTator, text mining | PubMed |
| Epigenetic disruption of adipogenic gene enhancers in dedifferentiated liposarcomas and its therapeutic value. | Front Oncol | 2025 | 40371227 | PubTator, text mining | PubMed |
| PRMT1-Mediated SWI/SNF Complex Recruitment via SMARCC1 Drives IGF2BP2 Transcription to Enhance Carboplatin Resistance in Head and Neck Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2025 | 40270464 | PubTator, text mining | PubMed |
| SMARCC1 promotes M2 macrophage polarization and reduces ferroptosis in lung cancer by activating FLOT1 transcription. | J Mol Med (Berl) | 2025 | 40108025 | PubTator, text mining | PubMed |
| Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma. | J Transl Med | 2025 | 40011918 | PubTator, text mining | PubMed |
| FOXF2 expression triggered by endocrine therapy orchestrates therapeutic resistance through reorganization of chromatin architecture in breast cancer. | Cancer Lett | 2025 | 39828125 | PubTator, text mining | PubMed |
| Identification of assembly mode of non-canonical BAF (ncBAF) chromatin remodeling complex core module. | Biochem Biophys Res Commun | 2025 | 39732119 | PubTator, text mining | PubMed |
| De novo variants disrupt an LDB1-regulated transcriptional network in congenital ventriculomegaly. | Brain | 2025 | 39680505 | PubTator, text mining | PubMed |
| Absence of SMARCB1 in rhabdoid tumor cells increases sensitivity to translation inhibition and alters translation efficiency of specific mRNAs. | J Biol Chem | 2024 | 39542244 | PubTator, text mining | PubMed |
| Overexpression of Chromatin Remodeling Factor SRG3 Down-Regulates IL1β-Expressing M1 Macrophages and IL17-Producing T Cells in Adipose Tissues. | Int J Mol Sci | 2024 | 39519233 | PubTator, text mining | PubMed |
| A proteome-wide association study identifies putative causal proteins for breast cancer risk. | Br J Cancer | 2024 | 39468330 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6599/papers?page=2